Search Results 1-7 of 7

KUBOTA Masaya , SHIMIZU Masahito , BABA Atsushi , OHNO Tomohiko , KOCHI Takahiro , SHIRAKAMI Yohei , MORIWAKI Hisataka

… The prognosis of patients with hepatocellular carcinoma (HCC) is poor and the development of effective treatments for this malignancy, including combination chemotherapy, is required. … Combined treatment with bevacizumab plus ACR significantly suppressed the growth of Huh7 xenografts. … With combination therapy, the population of Ki-67-positive cells in xenografts decreased, while that of TUNEL-positive cells increased. …

Journal of Nutritional Science and Vitaminology 60(5), 357-362, 2014

J-STAGE  Ichushi Web 

JIA Wei-Dong , XU Ge-Liang , WANG Wei , WANG Zhi-Hua , LI Jian-Sheng , MA Jin-Liang , REN Wei-Hua , GE Yong-Sheng , YU Ji-Hai , LIU Wen-Bin

… Occurrence of second primary tumors and metastasis remains the major obstacles to prolonged survival of patients with primary hepatocellular carcinoma (HCC). … A somatostatin analogue, octreotide, has been previously reported to inhibit the growth of human HCC xenografts in nude mice through its anti-angiogenic activity. …

The Tohoku Journal of Experimental Medicine 218(2), 155-160, 2009-06-01

J-STAGE  References (30)

KAWASHITA Y

Gene Ther 12, 1633-1639, 2005

DOI  Cited by (1)

YAMAMOTO C.

Hepatology 30, 894-902, 1999

DOI  Cited by (5)